Sentence examples for efficacy in the case of from inspiring English sources

To date a poor accessibility of the tumor mass and a hostile microenvironment, influenced by genetic and epigenetic instability, mainly limit ACT therapeutic efficacy in the case of solid tumors.

Data processing can be upgraded with non-standard features added on request as shown in two examples: (1) the testing of splenectomy efficacy in the case of thrombocytopenia with normal production; and (2) the detection and localisation of parathyroid adenomas.

As reported in several recent reviews, the rate of irrelevant positives (i.e. low specificity) for some studies using in vitro methods (when compared to this "gold standard") means that an increased number of test articles are subjected to additional in vivo genotoxicity testing, in many cases before, e.g. the efficacy (in the case of pharmaceuticals) of the compound has been evaluated.

Both control- and Taxol-treated animals encountered significant weight loss by day 25, indicating disease progression and limited efficacy in the case of intermittent Taxol therapy.

17– 19 This novel approach has proven its efficacy in the case of multiple sclerosis, 20 malaria, 21 human immunodeficiency virus, 22 and tuberculosis, 23 with desired results.

Side effects, withdrawal and/or complication rates will be studied in the same way as those described for the quantification of the efficacy in the case of qualitative variables.

Pharmacology and psychotherapy stand for the conventional treatment for anxiety disorders but these present limited efficacy, especially in the case of chronic anxiety, with high relapse rates and often causing adverse side effects.

A spokeswoman for Johnson & Johnson, which owns Piz Buin, said: "Our products are subject to rigorous safety and efficacy testing; in the case of sun care products, this includes SPF testing in line with the EU sun care recommendation".

Although hypoglycaemia rates are naturally higher when treating with insulin, the marked improvements in efficacy and, in the case of IDeg, the possibility of flexibility with regard to dose timing when needed, support the benefits of earlier initiation of basal insulin in relevant patient groups.

Adoption of screening policies between the ages of 50 and 80 will only eradicate a small portion (between 14%-24 14%-24he existing colorectal cancer burden, since the application of the compliancy rate to the intervention efficacy, even in the case of colonoscopy every 10 years will only result in a 24.1% reductiof in incidence.

The inserted genes can be used to enhance therapeutic efficacy as in the case of a GLAF-1 (a single chain antibody against vascular endothelial growth factor (VEGF)) encoding VACV [ 13], or to allow the use of imaging techniques such as positron emission tomography (PET) [ 14, 15].